AstraZeneca reported 19.54B in Current Assets for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Alcon AG ALC:SW 4.99B 207M
Amgen AMGN:US $ 21299M 155M
Artemis Alpha ATS:LN 868K 5.59M
Astrazeneca AZN:US 18.74B 809M
Bayer BAYN:GR 35.66B 3.68B
Biogen BIIB:US $ 6719.5M 167.6M
Bristol Myers Squibb BMY:US $ 27111M 3081M
Eli Lilly And LLY:US $ 16604.5M 857.6M
Fresenius FRE:GR € 15772M 1061M
Fresenius Medical Care FME:GR € 7275.31M 548.76M
Galapagos GLPG:NA 5.37B 94.42M
Genmab GEN:DC 18.79B 713M
Gilead Sciences GILD:US $ 13166M 2830M
GlaxoSmithKline GSK:LN 18.52B 1.72B
GRIFOLS GRF:SM € 3164.95M 478.66M
H. Lundbeck A/S LUN:DC 10.1B 240M
Hikma Pharmaceutical HIK:LN 1.92B 44M
Novartis NOVN:VX 29.67B 700M
Recordati REC:IM 772.95M 106.21M
Regeneron Pharmaceuticals REGN:US $ 10055.1M 276M